Filing Details

Accession Number:
0001209191-20-021159
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-25 17:28:50
Reporting Period:
2020-03-20
Accepted Time:
2020-03-25 17:28:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501756 Adverum Biotechnologies Inc. ADVM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1233539 D Leone Patterson C/O Adverum Biotechnologies, Inc.
800 Saginaw Drive
Redwood City CA 94063
Ceo, President And Director Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-20 24,424 $3.44 162,955 No 4 M Direct
Common Stock Disposition 2020-03-20 39,526 $10.17 123,429 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-03-20 24,424 $0.00 24,424 $3.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
175,576 2026-06-15 No 4 M Direct
Footnotes
  1. This transaction was pursuant to a 10b5-1 Plan.
  2. Represents weighted average sales price. The shares were sold at prices ranging from $10.00 to $10.58. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Twenty-Five Percent (25%) of the total shares subject to the option vest and become exercisable on the first anniversary of the Vesting Commencement Date, and 1/48 of the total shares subject to the option shall vest and become exercisable each month thereafter, such that all of the shares subject to the option shall be vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.